EMMAC Life Sciences Revenue and Competitors

London, UK

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • EMMAC Life Sciences's estimated annual revenue is currently $10.2M per year.(i)
  • EMMAC Life Sciences's estimated revenue per employee is $155,000

Employee Data

  • EMMAC Life Sciences has 66 Employees.(i)

EMMAC Life Sciences's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.5M29-12%N/AN/A
#2
$15.7M1015%N/AN/A
#3
$87.9M40525%$292MN/A
#4
$2.6M47016%$631.7MN/A
#5
$14.9M96-8%$81MN/A
#6
$44.8M2310%$132.9MN/A
#7
$7.6M49-37%N/AN/A
#8
$17.4M11212%N/AN/A
#9
$334.6M134911%£994.6MN/A
#10
$830.2M53568%N/AN/A
Add Company

What Is EMMAC Life Sciences?

EMMAC was incorporated to capitalise on the existing medical cannabis industry in Europe, as well as the enormous market opportunities presented by the Continent's increasing pace of, and pressure for, deregulation.

keywords:N/A

N/A

Total Funding

66

Number of Employees

$10.2M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

EMMAC Life Sciences News

2022-04-19 - 3 Reasons to Buy Curaleaf Stock on the Dip

Last year, it completed the acquisition of EMMAC Life Sciences Group, also completing its successful rebranding to Curaleaf International.

2022-04-17 - How CBD biomanufacturing could make Europe change and ...

Scientific publications about CBD since 1980. ... GW Pharma (acquired by Jazz Pharmaceuticals), EMMAC Life Sciences (acquired by Curaleaf)...

2022-04-06 - Curaleaf International: New Poll Shows European market is Ready for Legal Recreational Cannabis

Curaleaf International (formerly EMMAC Life Sciences Group) is Europe's largest vertically integrated cannabis company, bringing together...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.1M660%N/A
#2
$7.1M6640%N/A
#3
$13.5M66-3%N/A
#4
$8.6M6629%N/A
#5
$8.6M66-16%N/A